| ID | Assay | Related subunit | Celltype | Tissue | Disease | Treatment1 | Treatment2 | Study | Download1 | Download2 |
|---|---|---|---|---|---|---|---|---|---|---|
| CDBD02041 | HiC | None | SK-N-SH | Neural | Cancer | heterozygous | NT | GSE115862 | ||
| CDBD02040 | HiC | None | SK-N-SH | Neural | Cancer | NT | NT | GSE115862 | ||
| CDBD01470 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEsensitive | GSE126792 | ||
| CDBD01469 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEsensitive | GSE126792 | ||
| CDBD01468 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEsensitive | GSE126792 | ||
| CDBD01467 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEresistant | GSE126792 | ||
| CDBD01466 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEresistant | GSE126792 | ||
| CDBD01465 | HiChIP | SMC1 | Kelly | Neural | Cancer | NT | TAEresistant | GSE126792 | ||
| CDBD01394 | HiC | None | H1-NPC | Neural | Normal | NT | NT | GSE52457 | ||
| CDBD00113 | ChIAPET | SMC1 | Kelly | Neural | Cancer | TAEresistant | NT | GSE115252 | ||
| CDBD00112 | ChIAPET | SMC1 | Kelly | Neural | Cancer | TAEresistant | NT | GSE115252 | ||
| CDBD00111 | ChIAPET | SMC1 | Kelly | Neural | Cancer | TAEresistant+shBORIS | NT | GSE115252 | ||
| CDBD00110 | ChIAPET | SMC1 | Kelly | Neural | Cancer | TAEresistant+shBORIS | NT | GSE115252 | ||
| CDBD00109 | ChIAPET | SMC1 | Kelly | Neural | Cancer | TAEresistant | NT | GSE103148 | ||
| CDBD00108 | ChIAPET | SMC1 | Kelly | Neural | Cancer | NT | NT | GSE103148 | ||
| CDBD00065 | ChIAPET | CTCF | SK-N-SH | Neural | Cancer | NT | NT | ENCSR514HBO | ||
| CDBD00064 | ChIAPET | CTCF | SK-N-SH | Neural | Cancer | NT | NT | ENCSR514HBO | ||
| CDBD00025 | ChIAPET | Rad21 | NPC-H9 | Neural | Normal | NT | NT | ENCSR247RGI | ||
| CDBD00024 | ChIAPET | Rad21 | NPC-H9 | Neural | Normal | NT | NT | ENCSR247RGI |